• Standard Curve for Human Cystatin C: Capture Antibody Mouse mAb [6F12-C7-D8] to Human Cystatin C at 4 Mu g/ml and Detector Antibody Mouse mAb [7F6-A5-F3]to Human Cystatin C at 0.5 Mu g/ml.

Anti-CST3 antibody [6F12-C7-D8] (STJ99195)

SKU:
STJ99195

Current Stock:
Host: Mouse
Applications: ELISA
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Mouse monoclonal antibody anti-Cystatin-C is suitable for use in ELISA research applications.
Clonality: Monoclonal
Clone ID: 6F12-C7-D8
Conjugation: Unconjugated
Isotype: IgG1
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from mouse ascites by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: ELISA 1:10000-20000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: CST3
Gene ID: 1471
Uniprot ID: CYTC_HUMAN
Immunogen: Recombinant human cystatin c protein.
Post Translational Modifications The Thr-25 variant is O-glycosylated with a core 1 or possibly core 8 glycan. The signal peptide of the O-glycosylated Thr-25 variant is cleaved between Ala-20 and Val-21.
Function As an inhibitor of cysteine proteinases, this protein is thought to serve an important physiological role as a local regulator of this enzyme activity.
Protein Name Cystatin-C
Cystatin-3
Gamma-Trace
Neuroendocrine Basic Polypeptide
Post-Gamma-Globulin
Database Links Reactome: R-HSA-381426
Reactome: R-HSA-6798695
Reactome: R-HSA-8957275
Reactome: R-HSA-977225
Cellular Localisation Secreted
Alternative Antibody Names Anti-Cystatin-C antibody
Anti-Cystatin-3 antibody
Anti-Gamma-Trace antibody
Anti-Neuroendocrine Basic Polypeptide antibody
Anti-Post-Gamma-Globulin antibody
Anti-CST3 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance